desloratadine has been researched along with Bronchial Hyperreactivity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, SD; Brannan, JD; Currie, GP; Fowler, SJ; Haggart, K; Lee, DK; Lipworth, BJ; Wilson, AM | 1 |
| Bryce, PJ; Geha, R; Oettgen, HC | 1 |
| Blümchen, K; Gerhold, K; Hamelmann, E; Seib, C; Thorade, I; Wahn, U | 1 |
| Adalioglu, G; Dizdar, EA; Dogan, C; Kalayci, O; Keskin, O; Sekerel, BE; Tuncer, A | 1 |
2 trial(s) available for desloratadine and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Effects of mediator antagonism on mannitol and adenosine monophosphate challenges.
Topics: Acetates; Adenosine Monophosphate; Adult; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Loratadine; Male; Mannitol; Middle Aged; Quinolines; Sulfides; Time Factors | 2003 |
The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis.
Topics: Adolescent; Albuterol; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Bronchodilator Agents; Child; Drug Administration Schedule; Eosinophil Cationic Protein; Eosinophils; Ephedrine; Female; Forced Expiratory Volume; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Loratadine; Male; Methacholine Chloride; Nasal Mucosa; Nasal Provocation Tests; Pollen; Prospective Studies; Rhinitis, Allergic, Seasonal; Secretory Rate | 2007 |
3 other study(ies) available for desloratadine and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma.
Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Histamine H1 Antagonists, Non-Sedating; Immunoglobulin E; Inflammation; Loratadine; Mice; Mice, Inbred BALB C; Ovalbumin; Receptors, Histamine H1; T-Lymphocytes | 2003 |
Oral administration of desloratadine prior to sensitization prevents allergen-induced airway inflammation and hyper-reactivity in mice.
Topics: Administration, Oral; Allergens; Animals; Bronchial Hyperreactivity; Cells, Cultured; Female; Histamine H1 Antagonists; Hypersensitivity; Immunoglobulin E; Immunoglobulin G; Interleukin-4; Interleukin-5; Loratadine; Lung; Lymph Nodes; Mice; Mice, Inbred BALB C; Models, Animal; Ovalbumin; Spleen | 2004 |
[The third-generation antihistaminics. Can they prevent the tier change?].
Topics: Asthma; Bronchial Hyperreactivity; Histamine H1 Antagonists; Humans; Loratadine; Placebos; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Seasonal; Risk Factors | 2002 |